Breaking News Instant updates and real-time market news.

KO

Coca-Cola

$48.84

-0.24 (-0.49%)

12:08
12/10/18
12/10
12:08
12/10/18
12:08

Coca-Cola hires broker to sell iconic Fifth Avenue building, Bloomberg says

Coca-Cola has enlisted real estate broker Cushman & Wakefield to sell a midtown Manhattan building known as the Coca-Cola Building, says Bloomberg. The 18-story property was inherited by Coca-Cola in 1983, through its purchase of Columbia Pictures, added the report. Coca-Cola "has determined that it does not need to retain its investment in the building to support its activities in New York," according to a statement. Reference Link

  • 18

    Dec

  • 18

    Dec

  • 03

    Mar

KO Coca-Cola
$48.84

-0.24 (-0.49%)

11/08/18
SUSQ
11/08/18
NO CHANGE
Target $46
SUSQ
Negative
Monster Beverage results solid, but Coke conflict an overhang, says Susquehanna
Susquehanna analyst Pablo Zuanic said Monster Beverage (MNST) reported solid Q3 earnings, though gross margins missed again. However, he thinks a price hike effective on November 1 should mitigate the gross margin pressure. He believes a budding conflict with Coca-Cola (KO) could call into question the company's ability to grow and will be an overhang on the stock. Zuanic reiterated his Negative rating, though he raised his price target to $46 from $44 on Monster Beverage shares.
11/09/18
SBSH
11/09/18
NO CHANGE
Target $56
SBSH
Buy
Coca-Cola should trade at a 50% premium to market, says Citi
After spending time in Europe with CEO James Quincey, Citi analyst Wendy Nicholson says her confidence in Coca-Cola "continues to go up." Given her confidence in the company's ability to deliver on its growth targets, she continues to believe the stock should trade at a 50% premium to the market. The analyst raised her price target for Coca-Cola shares to $56 from $54 and keeps a Buy rating on the name.
11/09/18
BMOC
11/09/18
NO CHANGE
Target $60
BMOC
Outperform
Monster Beverage price target lowered to $60 from $70 at BMO Capital
BMO Capital analyst Amit Sharma lowered his price target on Monster Beverage (MNST) to $60 to reflect its selloff yesterday on reported possibility of Coca-Cola (KO) entering the energy drink category. The analyst notes however that while the threat may pose a near-term overhang on the stock, the impact on its growth and valuation is likely overblown. Sharma cites the "deep economic alignment" between the two companies and their bottlers, along with the company's willingness to find an acceptable resolution. The analyst also keeps his Outperform rating on Monster Beverage.
11/09/18
GSCO
11/09/18
UPGRADE
Target $66
GSCO
Conviction Buy
Monster Beverage upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Judy Hong added Monster Beverage to the Conviction Buy List saying concerns over the dispute Coca-Cola (KO) are overdone and recommends buying shares on weakness. Hong believes Monster's shares downside is limited from a Coca-Cola Energy launch and does not believe the partnership is in jeopardy. The analyst sees upside to consensus 2019/20 estimates and a path to her $66 price target based on mid-teens plus earnings growth.

TODAY'S FREE FLY STORIES

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:26
11/14/19
11/14
16:26
11/14/19
16:26
Hot Stocks
Nvidia reports Q4 Gaming segment revenue $1.66B, down 6% from last year »

Reports Q4 Data Center…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

DLPN

Dolphin Entertainment

$0.70

(0.00%)

16:25
11/14/19
11/14
16:25
11/14/19
16:25
Earnings
Dolphin Entertainment reports Q3 EPS (5c), consensus (6c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$76.75

-0.38 (-0.49%)

16:25
11/14/19
11/14
16:25
11/14/19
16:25
Initiation
Agilent initiated  »

Agilent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

BGNE

BeiGene

$196.65

-0.5 (-0.25%)

16:23
11/14/19
11/14
16:23
11/14/19
16:23
Hot Stocks
BeiGene says FDA grants accelerated approval for BRUKINSA »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 27

    Feb

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:23
11/14/19
11/14
16:23
11/14/19
16:23
Earnings
Nvidia sees Q4 revenue $2.95B, +/- 2%, consensus $3.06B »

Sees Q4 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

OSMT

Osmotica Pharmaceuticals

$4.00

-0.03 (-0.74%)

16:23
11/14/19
11/14
16:23
11/14/19
16:23
Earnings
Osmotica Pharmaceuticals reports Q3 EPS ($2.15), consensus (23c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BOX

Box

$15.82

-0.38 (-2.35%)

, CARS

Cars.com

$12.56

0.48 (3.97%)

16:22
11/14/19
11/14
16:22
11/14/19
16:22
Hot Stocks
Starboard adds 7M shares of Box in Q3, exits Cars.com and Dollar Tree »

Jeffrey Smith's…

BOX

Box

$15.82

-0.38 (-2.35%)

CARS

Cars.com

$12.56

0.48 (3.97%)

DLTR

Dollar Tree

$108.71

0.305 (0.28%)

MRVL

Marvell

$26.98

-1.13 (-4.02%)

NTUS

Natus Medical

$31.54

-0.56 (-1.74%)

KAR

KAR Auction

$22.80

0.88 (4.01%)

NLOK

NortonLifeLock

$24.52

-0.05 (-0.20%)

ACM

Aecom

$43.49

1.275 (3.02%)

CERN

Cerner

$67.03

0.25 (0.37%)

PRGO

Perrigo

$48.03

-0.385 (-0.80%)

AAP

Advance Auto Parts

$156.93

-1.52 (-0.96%)

RPM

RPM

$74.62

0.915 (1.24%)

EBAY

eBay

$34.95

0.3 (0.87%)

SCOR

comScore

$3.98

(0.00%)

IWN

iShares Russell 2000 Value Index

$124.16

-0.03 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 26

    Nov

  • 03

    Dec

  • 04

    Dec

  • 09

    Dec

  • 06

    Jan

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:22
11/14/19
11/14
16:22
11/14/19
16:22
Hot Stocks
Nvidia to return to stock buybacks after closing Mellanox deal in early FY20 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:21
11/14/19
11/14
16:21
11/14/19
16:21
Hot Stocks
Nvidia CEO says gaming business and hyperscale demand powered Q3 results »

CEO Jensen Huang says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

UVE

Universal Insurance

$30.07

-0.43 (-1.41%)

16:21
11/14/19
11/14
16:21
11/14/19
16:21
Hot Stocks
Universal Insurance declares regular, special cash dividend »

Universal Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRE

Aprea Therapeutics

$26.92

2.45 (10.01%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Earnings
Aprea Therapeutics reports Q3 EPS ($5.29), consensus ($3.94) »

As of September 30, prior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Earnings
Nvidia reports Q3 adjusted EPS $1.78, consensus $1.57 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Options
Closing CBOE SPX and VIX Index summary for November 14th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$175.21

2 (1.15%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Hot Stocks
Breaking Hot Stocks news story on RH »

RH up 7% in afterhours…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Earnings
Dolby sees FY20 adjusted EPS $3.40-$3.50, consensus $2.87 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

CSSE

Chicken Soup for the Soul

$9.99

0.28 (2.88%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Earnings
Chicken Soup for the Soul reports Q3 adjusted EPS ($1.03), consensus (5c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Earnings
Dolby sees Q1 adjusted EPS 45c-51c, consensus 65c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

CY

Cypress Semiconductor

$23.43

0.01 (0.04%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Downgrade
Cypress Semiconductor rating change  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$91.26

-0.02 (-0.02%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Hot Stocks
Nike raises quarterly dividend to 24.5c from 22c per share »

The dividend declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$109.21

4.195 (3.99%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Earnings
Globant raises FY19 non-IFRS EPS view to $2.23-$2.27 from $2.19-$2.25 »

Consensus $2.24. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSN

Celsion

$1.38

0.29 (26.73%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Celsion reports Q3 EPS (25c), consensus (28c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

HAYN

Haynes

$35.83

-0.31 (-0.86%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Haynes reports Q4 EPS 48c, consensus 40c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Dolby reports Q4 adjusted EPS 66c, consensus 48c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

GLOB

Globant

$109.21

4.195 (3.99%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Globant sees Q4 non-IFRS adjusted EPS 58c-62c, consensus 63c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.